Page 2 - Vaccine
ICMR to advance 1st in-human trials for Zika, flu, blood cancer therapies
First-in-human trial is a type of clinical trial in which a new drug, procedure or treatment is tested in humans for the first time
WHO grants first mpox vaccine approval to enhance response in Africa
The World Health Organisation on Friday said it has granted its first authorisation for use of a vaccine against mpox in adults, calling it an important step toward fighting the disease in Africa and beyond. The pre-qualification of the vaccine by Bavarian Nordic A/S means that donors like GAVI the Vaccine Alliance and UNICEF can buy it. But supplies are limited because there's only a single manufacturer. This first pre-qualification of a vaccine against mpox is an important step in our fight against the disease, both in the context of the current outbreaks in Africa, and in future, said WHO Director-General Tedros Adhanom Ghebreyesus. The UN health agency chief called for urgent scale-up of procurement, donations and rollout to get the vaccine where it is needed most, along with other response measures. Under the WHO authorisation, the vaccine can be administered in people aged 18 or above in a two-dose regimen. The approval says that while the vaccine is not currently licensed fo
Africa's doses fall short amid Mpox spread while rich nations have plenty
A small fraction of those doses could help curb what is now the biggest mpox outbreak on record in the Democratic Republic of Congo and neighboring countries, disease experts say
DFC commits long-term loan of $20 mn to Panacea Biotec to expand operations
US International Development Finance Corporation (DFC) has committed a long-term loan of up to USD 20 million to Panacea Biotec, the company said on Thursday. Panacea is expanding the manufacturing capacity for drug substance antigens used in its hexavalent vaccine EasySix to meet future demand from UN agencies and public health organisations. DFC has agreed to provide a long-term loan of up to USD 20 million to the company to help finance this project, the biotechnology firm said in a regulatory filing. DFC's financing will enable Panacea Biotec to expedite the completion of the ongoing expansion and supply the hexavalent vaccine to UN agencies for childhood immunisation globally, it added. "Our hexavalent vaccine EasySix, which meets the highest standards of safety and efficacy, will have a meaningful impact on the lives of millions of newborns in the developing world," Panacea Biotec Chairman and MD Rajesh Jain said. DFC Deputy CEO Nisha Biswal said the organisation's partnersh
Canada to donate 'up to 200,000' doses of mpox vaccine: Govt official
Canada would not say to whom it would deliver the vaccines, or in what time frame
One Bavarian Nordic smallpox shot 58% effective against Mpox, shows study
One vaccination provided about 58 per cent protection against Mpox infection, researchers found in the study
Bharat Biotech, Alopexx partner to develop new broad-spectrum vaccine
Bharat Biotech, based in Genome Valley, Hyderabad, has a portfolio of vaccines and bio-therapeutics, including COVID-19 vaccines and novel vaccines for various infectious diseases
Bharat Biotech partners with Alopexx to develop anti-microbial vaccine
Bharat Biotech on Wednesday announced a collaboration with Alopexx Inc for development and commercialisation of the latter's broad-spectrum anti-microbial vaccine in India and other low income countries. As part of the collaboration, the companies will co-develop and commercialise the vaccine -- AV0328, in India and other licensed territories, Bharat Biotech said in a statement. Alopexx would be entitled to a one-time upfront payment and milestone payments, as well as royalties on future sales of AV0328 in the licensed territories, it added. "Our goal is to develop solutions to reduce anti-microbial resistance through vaccination. This collaboration aligns with our mission to provide safe, affordable, and high-quality vaccines to combat infectious diseases globally," Bharat Biotech Executive Chairman Krishna Ella said. Alopexx CEO Daniel Vlock said, this collaboration brings the company one step closer to addressing the critical need for affordable, broad-spectrum antimicrobial ..
Higher price of mpox vaccine to pose key hurdle in Africa order talks
But with a shot significantly pricier than many other vaccines commonly used for immunisation in Africa, costs remain a key barrier to getting more orders in place
FAME-III likely to see vehicles sporting government subsidy branding
Move aims to highlight Centre's electric mobility schemes and ensure greater transparency
Congo receives its first mpox vaccine shipment to combat outbreak
With a population of around 100 million, the Congo is currently at the centre of the outbreak
Unicef issues tender to secure mpox vaccines for most-affected countries
The emergency tender is designed not only to secure immediate access to mpox vaccines but also to expand production
IIL develops live-attenuated, needle-free intranasal Covid-19 vaccine
The contagion still killing 1,700 people every week across the world, says WHO
Bharat Biotech launches oral cholera vaccine after positive phase 3 trial
Bharat Biotech in a release said it plans to bridge a worldwide deficit of 40 million doses per year through Hillchol
WHO partners can start talks to buy mpox vaccines before approval
Earlier this month, the WHO asked vaccine manufacturers to submit information so it could accelerate its approval process, and grant an emergency licence by mid-September
AstraZeneca warns of shifting UK vaccine production to US: Report
An AztraZeneca spokesperson said there are no discussions in the US or India as the company is committed to pursuing the opportunity at Speke and are in constructive talks with the UK government
Expects positive news on indigenous Mpox vaccine within a year: Poonawalla
Mpox cases have been confirmed among children and adults in more than a dozen African countries, and a new form of the virus is spreading
How lack of coordination, funding issues turned mpox into a global crisis
The chain of delayed reactions to the crisis began during the last mpox emergency that ended in 2023
India's health system on alert as viral infection mpox scare grows
Hyderabad and New Delhi, which serve as popular destinations for students from Africa to pursue higher education, are also on alert after the news
WHO calls for surveillance, sharing of vaccines to combat mpox outbreak
Recently, Sweden confirmed the first case of mpox Clade I, a viral infection that spreads through close contact
